ELIZABETH SARA OOMMEN
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism ALBANY, NY NPI 1972943751
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism NY Lilly USA, LLC All categories
General Payments — all program years on this page
$12,711.05
- Category: General Payments
- Program years: PY2018–2024
- Record count: 506
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,043.81 across 98 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,031.56 | 97 |
| Education | $12.25 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $526.98 | 29 |
| Xeris Pharmaceuticals, Inc. | $258.36 | 8 |
| Abbott Laboratories | $144.32 | 7 |
| Bayer HealthCare Pharmaceuticals Inc. | $115.43 | 7 |
| RECORDATI_RARE_DISEASES_INC. | $108.95 | 5 |
| Amgen Inc. | $106.33 | 6 |
| BETA BIONICS, INC. | $101.34 | 2 |
| SANOFI-AVENTIS U.S. LLC | $98.24 | 4 |
| DEXCOM, INC. | $88.78 | 4 |
| Antares Pharma, Inc. | $70.57 | 4 |
| Radius Health, Inc. | $57.39 | 3 |
| IBSA Pharma Inc. | $48.58 | 3 |
| Novo Nordisk AS | $48.55 | 3 |
| MannKind Corporation | $41.40 | 3 |
| Averitas Pharma Inc. | $41.19 | 1 |
| ABBVIE INC. | $34.14 | 1 |
| Alexion Pharmaceuticals, Inc. | $30.78 | 2 |
| Tandem Diabetes Care, Inc. | $29.06 | 1 |
| Medtronic, Inc. | $27.55 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.11 | 1 |
| RGH ENTERPRISES LLC | $17.57 | 1 |
| PFIZER INC. | $15.84 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.35 | 1 |
By program year
Records — PY2024 (98)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.